Changes in Management Of Karo Bio AB

19-Aug-2011 - Sweden

Karo Bio AB announced that Jens Kristensen, Chief Medical Officer and Vice President Preclinical Development and Regulatory affairs, leaves his position.

Acting President and CEO Per Bengtsson will temporarily assume management responsibility for clinical development and regulatory affairs until a new Chief Medical Officer has been recruited. The change in management will not affect the clinical development plan of eprotirome.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances